CRNX SCHEDULE 13G/A: SEC filing

Wellington Management Group LLP

Filed with the SEC on · accession 0000902219-26-000377

CRNX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Wellington Management Group LLP filed an amended Schedule 13G indicating it beneficially owns 0% of Crinetics Pharmaceuticals common stock, effectively reporting no holdings as of September 30, 2026.

Key details

Shares beneficially owned$0
Percent of class beneficially owned$0
Filer / former beneficial ownerWellington Management Group LLP
IssuerCrinetics Pharmaceuticals, Inc.
Compliance managerMatthew Revell

✦ Ask GOAX AI about this filing — what it means for CRNX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CRNX?

Click here

Frequently asked questions

What did CRNX file with the SEC on Nov 16, 2026?

CRNX filed a SCHEDULE 13G/A (SEC filing). Wellington Management Group LLP filed an amended Schedule 13G indicating it beneficially owns 0% of Crinetics Pharmaceuticals common stock, effectively reporting no holdings as of September 30, 2026.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other CRNX SEC filings

Get alerts when CRNX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days